Literature DB >> 9499794

Conservation of the architecture of the Golgi apparatus related to a differential organization of microtubules in polykaryocytes induced by syn- mutants of herpes simplex virus 1.

P L Ward1, E Avitabile, G Campadelli-Fiume, B Roizman.   

Abstract

Infection of Vero and HEp-2 but not of 143TK- cells with herpes simplex virus 1 results in fragmentation and dispersal of the Golgi apparatus. Concurrently, in all three infected cell lines the microtubular network is disrupted, suggesting that the disruption of microtubules is essential but not sufficient to induce the fragmentation of the Golgi apparatus. We now report the following: (i) In polykaryocytes formed in Vero cells infected with HSV-1 syn- mutant viruses, intact Golgi stacks were readily detected by electron microscopy. These aggregated in the center of large polykaryocytes. (ii) The distribution of viral glycoprotein D, examined in both fixed and nonfixed cells, appeared to match the distribution of the Golgi stacks, suggesting that the aggregated Golgi stacks funnel viral glycoproteins and viral particles to a limited region of the plasma membrane of the polykaryocytes rather than directing exocytic flow in a more dispersed fashion as seen in syn+ virus-infected cells exhibiting fragmented and dispersed Golgi. (iii) In most polykaryocytes, the microtubules formed parallel bundles extending along the axis of recruitment of new cells. (iv) Fragmentation of the microtubules at the periphery of the cell near the plasma membrane was observed in untreated or cycloheximide-treated cells 2 h after infection with syn- virus HSV-1(MP) or syn+ HSV-1(mP) but not in mock-infected cells. These observations suggest that peripheral depolymerization is initiated at the time of infection and that a factor which determines the syn- or syn+ phenotype is whether the microtubular network regenerates concomitant with cell fusion or reorganizes to form a collapsed network surrounding nuclei of syn+ infected cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499794     DOI: 10.1006/viro.1997.8972

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Replication of herpes simplex virus: egress of progeny virus at specialized cell membrane sites.

Authors:  Rebecca M Mingo; Jun Han; William W Newcomb; Jay C Brown
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Identification of a highly conserved, functional nuclear localization signal within the N-terminal region of herpes simplex virus type 1 VP1-2 tegument protein.

Authors:  F Abaitua; P O'Hare
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

3.  Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection.

Authors:  L E Pomeranz; J A Blaho
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Role of tumor invasiveness, the extracellular matrix, and chromatin sequestration in the susceptibility of uveal melanoma to herpes simplex virus type 1.

Authors:  Klara Valyi-Nagy; Robert Folberg; Tibor Valyi-Nagy; Andrew J Maniotis
Journal:  Exp Eye Res       Date:  2007-02-11       Impact factor: 3.467

5.  Subcellular localization of herpes simplex virus type 1 UL51 protein and role of palmitoylation in Golgi apparatus targeting.

Authors:  Naoki Nozawa; Tohru Daikoku; Tetsuo Koshizuka; Yohei Yamauchi; Tetsushi Yoshikawa; Yukihiro Nishiyama
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression.

Authors:  L Maresova; T J Pasieka; C Grose
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Herpes simplex virus dances with amyloid precursor protein while exiting the cell.

Authors:  Shi-Bin Cheng; Paulette Ferland; Paul Webster; Elaine L Bearer
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.